Back to Search
Start Over
Vertex Pharmaceuticals price target raised by $25 at TD Cowen, here's why
- Source :
- The Fly. August 2, 2024
- Publication Year :
- 2024
-
Abstract
- TD Cowen raised the firm's price target on Vertex Pharmaceuticals to $525 from $500 and keeps a Buy rating on the shares. The firm said Q2 reuslts were inline and [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.803557473